HYPERION DEFI, INC. Restricted Cash and Cash Equivalents
HYPERION DEFI, INC. (HYPD) had Restricted Cash and Cash Equivalents of $7.88 million as of 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2023-03-31
- 2022-12-31: Restricted Cash and Cash Equivalents $7.88M.
- 2022-09-30: Restricted Cash and Cash Equivalents $7.88M.
- 2022-06-30: Restricted Cash and Cash Equivalents $7.88M.
- 2022-03-31: Restricted Cash and Cash Equivalents $7.88M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2022-12-31 | $7.88M 10-K · filed 2023-03-31 |
| 2022-09-30 | $7.88M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $7.88M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $7.88M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $7.88M 10-K · filed 2022-03-30 |
| 2021-09-30 | $7.88M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |